Triple
T22692942
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | FIREFISH Part 2 |
E561096
|
entity |
| Predicate | instanceOf |
P0
|
FINISHED |
| Object | confirmatory efficacy and safety study |
C33574
|
CONCEPT FINISHED |
How this triple was built (1 step)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
CD
Concept disambiguation
gpt-5-mini-2025-08-07
Target class: confirmatory efficacy and safety study Context triple: [FIREFISH Part 2, instanceOf, confirmatory efficacy and safety study]
-
A.
clinical study
chosen
A clinical study is a structured research investigation involving human participants designed to evaluate the safety, efficacy, or outcomes of medical interventions, treatments, or health-related practices under predefined protocols.
-
B.
multicenter clinical study
A multicenter clinical study is a coordinated research trial conducted simultaneously at multiple geographically distinct sites under a common protocol to evaluate the safety, efficacy, or outcomes of a medical intervention in a diverse patient population.
-
C.
Alzheimer’s disease clinical trial
An Alzheimer’s disease clinical trial is a structured research study designed to evaluate the safety, tolerability, and effectiveness of investigational interventions aimed at preventing, slowing, or treating cognitive and functional decline associated with Alzheimer’s disease in human participants.
-
D.
reversal agent for factor Xa inhibitors
A reversal agent for factor Xa inhibitors is a therapeutic substance designed to rapidly neutralize the anticoagulant effects of factor Xa–inhibiting drugs in situations such as life-threatening bleeding or urgent surgery.
-
E.
COVID-19 vaccine trial
A COVID-19 vaccine trial is a structured clinical research study designed to evaluate the safety, immune response, and effectiveness of a candidate vaccine in preventing COVID-19 infection or severe disease in human participants.
- F. None of above.
Provenance (1 batch)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e2454d71b48190a1f80af9f82b6fcf |
completed | April 17, 2026, 2:35 p.m. |
Created at: April 17, 2026, 3:13 p.m.